CV Imaging of Metabolic Interventions
NCT05650307 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2026-05-08
Summary
Cardiovascular disease is the leading cause of death worldwide. It is becoming clearer that heart failure (HF) is closely associated with body's metabolism. Even before the heart becomes weaker, it responds to the stresses by changing the fuels it burns, which results in a reduction in the heart's metabolic efficiency that worsens the heart's condition. Since the heart burns so much fuel and consumes fats and carbohydrates along with other available substrates, any changes in its metabolic efficiency could impact metabolism throughout the body. Specifically, HF is characterized by limited flexibility in substrate utilization leading to an overall energetic deficit. Such energetic deficit is associated with progressive remodeling and alter cardiac hemodynamics. For example, obesity is a widely known risk factor for cardiovascular disease likely lie in how the heart handles energy (substrate utilization and energetics). One commonly recommended treatment for cardiovascular disease, especially coronary artery disease (CAD) or congestive heart failure (CHF), is cardiac rehabilitation. Cardiac rehabilitation for symptomatic cardiovascular disease has been shown to promote a healthy lifestyle, improve physical health and reduce cardiovascular death iii with an apparent dose-dependent response. Participation results in a reduced risk of hospitalization and revascularization procedures, and improved functional status in randomized controlled trials. Thus, cardiac rehabilitation is recommended for individuals with symptomatic CAD or CHF by the American College of Cardiology and American Heart Association. In addition, exercise training in preclinical animal models mirroring the exercise component of cardiac rehabilitation routines have shown increased myocardial regeneration and cardioprotective molecular effects ameliorating adverse myocardial remodeling. Despite these benefits, there is vast heterogeneity in the efficiency of cardiac rehabilitation on the individual level with large variances in improved exercise capacity and cardiac function recovery. Personalization of cardiac rehabilitation necessitates a non-invasive approach to monitor the direct beneficial effects on the heart and more ideally, predict efficacy at baseline. Taken together, understanding how metabolic interventions including bariatric surgery and cardiac rehabilitation change myocardial structure and function is critical for the prevention, diagnosis and prognosis for patients with cardiovascular diseases.
Advanced cardiovascular imaging using Magnetic Resonance Imaging (MRI) has proven to be effective in providing gold standard myocardial tissue characterization. Our team has developed novel cardiac MRI techniques that leverages endogenous tissue properties to reveal a milieu of deep tissue phenotypes including myocardial inflammation, fibrosis, metabolism, and microstructural defects. Among these phenotypes, myocardial microstructure has proven to be most sensitive to early myocardial tissue damage and is predictive of myocardial regeneration. In collaboration with cardiologists at Cleveland Clinic, the investigators aim to study how myocardial microstructure revealed by cardiac MRI changes cardiovascular disease patient population before and after metabolic interventions.
Conditions
- Bariatric Surgery Candidate
- Heart Failure
- Cardiovascular Diseases
Interventions
- DIAGNOSTIC_TEST
-
MRI
The magnetic field exposure for MRI in this study is similar to standard clinical MR procedures. The powers of all radio frequency fields in this study are at or under FDA guidelines. The CMR techniques performed here have been used in the literature and in our own clinical cardiac MRI service extensively for several years and have an excellent safety profile in our institution.
Sponsors & Collaborators
-
The Cleveland Clinic
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-09-09
- Primary Completion
- 2027-09-09
- Completion
- 2027-09-09
Countries
- United States
Study Locations
More Related Trials
-
Imaging-based Diagnosis of Diffuse Coronary Artery Disease and Quantification of Cardiac Remodeling in Obesity
NCT03046823 ·Status: COMPLETED
-
MRI Derived Organ & Tissue Mass Changes With Weight Loss - Ancillary to Look AHEAD
NCT00031200 ·Status: COMPLETED
-
Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance
NCT07131631 ·Status: RECRUITING
-
CMR Assessment of Cardiac Microvascular Dysfunction in Patients With HFpEF
NCT06316661 ·Status: RECRUITING
-
Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures
NCT00692991 ·Status: COMPLETED
-
Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI)
NCT04795856 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
New Heart Imaging Techniques to Evaluate Possible Heart Disease
NCT01399385 ·Status: RECRUITING ·Phase: NA
-
Cardiac Magnetic Resonance for Diagnosis, Treatment Guidance and Prognosis of Cardiac Masses (CMR)
NCT07335770 ·Status: ENROLLING_BY_INVITATION
-
Optimizing Image Quality in Obese Patients Undergoing Coronary Computed Tomography (CT) Angiography
NCT00468195 ·Status: COMPLETED
-
Heart Failure With Preserved Ejection Fraction and Its Cardiac MR Characteristics of Different Subtypes
NCT06916611 ·Status: ACTIVE_NOT_RECRUITING
-
Response of the Myocardium to Hypertrophic Conditions in the Adult Population
NCT02670031 ·Status: RECRUITING
-
Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH
NCT02631421 ·Status: COMPLETED
-
Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction
NCT07178145 ·Status: RECRUITING ·Phase: PHASE4
-
Ferumoxytol-enhanced Magnetic Resonance Imaging
NCT02954510 ·Status: UNKNOWN ·Phase: PHASE3
-
Ultra High Resolution CT to Assess Role of Intramyocardial Fat and Delayed Enhancement in Ventricular Arrhythmogenesis
NCT04394637 ·Status: ACTIVE_NOT_RECRUITING
-
Development of CIRC Technologies
NCT05654272 ·Status: RECRUITING
-
Noninvasive Imaging of Heart Failure: A Pilot Study
NCT01160471 ·Status: COMPLETED
-
MRI of Myocardial Infarction
NCT03531151 ·Status: COMPLETED
-
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
NCT01143454 ·Status: RECRUITING
-
Pericardiocentesis With Magnetic Resonance Imaging
NCT01479569 ·Status: TERMINATED ·Phase: PHASE1
-
Phenotypic Classification of FMR With CMR
NCT05965258 ·Status: RECRUITING
-
Cardiac Fibroblast Activation Detected by 68Ga-FAPI PET/MR
NCT04723953 ·Status: COMPLETED ·Phase: NA
-
Right Heart Dysfunction and Pulmonary Hypertension Evaluation in Airway Disease Using Cardiac Magnetic Resonance
NCT02865577 ·Status: COMPLETED
-
Multimodality Imaging in the Screening, Diagnosis and Risk StratifictiON of HFpEF
NCT04603404 ·Status: RECRUITING
-
The Interrogation of the Cardiomyopathy of Chronic Kidney Disease With advancEd caRdiac Imaging
NCT03704701 ·Status: TERMINATED